Price$6.05+0.62 (+11.42%)
01:30 PM07:45 PM
News · 26 weeks56-40%
2025-11-022026-04-26
Mix3590d
- SEC Filings13(37%)
- Insider11(31%)
- Earnings5(14%)
- Other3(9%)
- Analyst2(6%)
- Leadership1(3%)
Latest news
25 items- SECSEC Form 10-Q filed by Teladoc Health Inc.10-Q - Teladoc Health, Inc. (0001477449) (Filer)
- SECTeladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Teladoc Health, Inc. (0001477449) (Filer)
- PRTeladoc Health Reports First Quarter 2026 ResultsNEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 ("First Quarter 2026"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2025 ("First Quarter 2025"). Highlights First Quarter 2026 revenue of $613.8 million, down 2% year-over-yearFirst Quarter 2026 net loss of $63.8 million, or $0.36 per shareFirst Quarter 2026 adjusted EBITDA of $58.2 million, essentially flat year-over-yearIntegrated Care segment revenue of $395.4 million, up 2% year-over-year, and adjusted EBITDA margin of 14.2%BetterHelp segmen
- PRTeladoc Health to Announce First Quarter 2026 Financial ResultsNEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing (800) 715-9871 for U.S. participants and using the conference ID # 2214924. For international participants, please visit the following link for global dial-in numbers, using the same conference ID # 2214924: https://registrations.events/directory/international/itfs.html. A live audio webca
- SECSEC Form DEF 14A filed by Teladoc Health Inc.DEF 14A - Teladoc Health, Inc. (0001477449) (Filer)
- SECSEC Form DEFA14A filed by Teladoc Health Inc.DEFA14A - Teladoc Health, Inc. (0001477449) (Filer)
- INSIDERSEC Form 4 filed by Catapano Joseph Ronald4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERSEC Form 4 filed by Salka Susan R4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERSEC Form 3 filed by new insider Salka Susan R3 - Teladoc Health, Inc. (0001477449) (Issuer)
- SECTeladoc Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Teladoc Health, Inc. (0001477449) (Filer)
- PRTeladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of DirectorsNEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. She will serve on the board's audit and compensation committees. "Susan brings a powerful combination of healthcare leadership and governance experience to the Board," said Kenneth H. Paulus, non‑
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Teladoc Health Inc.SCHEDULE 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
- INSIDERAmendment: SEC Form 4 filed by President, U.S. Group Health Bliss Kelly4/A - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERCHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 64,653 shares and sold $152,243 worth of shares (27,731 units at $5.49), increasing direct ownership by 11% to 364,784 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- SECSEC Form 144 filed by Teladoc Health Inc.144 - Teladoc Health, Inc. (0001477449) (Subject)
- ANALYSTTeladoc upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded Teladoc from Hold to Buy and set a new price target of $11.00
- PRTeladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health's common stock, par value $0.001 per share ("Common Stock"), and an award of performance stock units covering a target of 57,034 shares of Common Stock (for which up to 114,068 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the
- INSIDERChief Accounting Officer Catapano Joseph Ronald converted options into 3,488 shares and sold $6,821 worth of shares (1,333 units at $5.12), increasing direct ownership by 32% to 8,841 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERCHIEF LEGAL OFFICER, SECRETARY Vandervoort Adam C converted options into 49,590 shares and sold $138,584 worth of shares (27,083 units at $5.12), increasing direct ownership by 28% to 103,239 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERCHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 176,971 shares and sold $256,592 worth of shares (50,145 units at $5.12), increasing direct ownership by 63% to 327,862 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERPresident, U.S. Group Health Bliss Kelly converted options into 51,340 shares and sold $136,353 worth of shares (26,647 units at $5.12), increasing direct ownership by 41% to 84,747 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- PRTeladoc Health to Participate in Upcoming Investor ConferenceNEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10th, 2026, at 1:00 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/. About Teladoc Health Teladoc Health (NYSE:TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health
- SECSEC Form 144 filed by Teladoc Health Inc.144 - Teladoc Health, Inc. (0001477449) (Subject)
- SECSEC Form 144 filed by Teladoc Health Inc.144 - Teladoc Health, Inc. (0001477449) (Subject)
- ANALYSTTeladoc upgraded by BofA Securities with a new price targetBofA Securities upgraded Teladoc from Neutral to Buy and set a new price target of $7.00
TDOC FAQ
7 questionsWhat does Teladoc Health Inc. do?
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers...Where does TDOC stock trade?
Teladoc Health Inc. (TDOC) is listed on NYSE.What sector and industry is TDOC in?
Teladoc Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did Teladoc Health Inc. go public?
Teladoc Health Inc. (TDOC) completed its IPO in 2015.What are analysts saying about TDOC?
Teladoc Health Inc. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Buy with a $1100.00 price target on 2026-03-10. Recent price targets range from $700.00 to $2200.00.What companies are similar to TDOC?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), AMED (Amedisys Inc), LHCG (LHC Group). Compare TDOC side-by-side with any of them on Quantisnow.How can I track TDOC on Quantisnow?
Quantisnow aggregates Teladoc Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TDOC to receive live email and push alerts on every new disclosure.